Načítá se...
Mast cell derived carboxypeptidase A3 is decreased among patients with advanced coronary artery disease
BACKGROUND: Coronary artery disease (CAD) affects milions of people and can result in myocardial infarction (MI). Previously, mast cells (MC) have been extensively investigated in the context of hypersensitivity, however as regulators of the local inflammatory response they can potentially contribut...
Uloženo v:
| Vydáno v: | Cardiol J |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Via Medica
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8083039/ https://ncbi.nlm.nih.gov/pubmed/29512095 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5603/CJ.a2018.0018 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|